News | June 14, 2007

Molecular Imaging of Diabetes Selected as 2007 Small Animal Image of the Year

June 15, 2007 - Avid Radiopharmaceuticals Inc. announced that a preclinical study presented at at the Society of Nuclear Medicine (SNM) Annual Meeting was selected as the 2007 Small Animal Image of the Year, showing a Positron Emission Tomography (PET) image of a rat pancreas following injection with AV-133, a molecular imaging agent.

The image highlighted the presentation entitled: “F-18 FP-DTBZ: An Investigational PET Ligand for Measuring Beta Cell Mass in the Pancreas,” with Drs. Mei-Ping Kung and Hank Kung as primary investigators. This study showed that AV-133, targeting the vesicular monoamine transporter-2 (VMAT2), is potentially useful for measurement of beta cell mass and for studying the pathogenesis of diabetes.

Declines in the number of beta cells in the pancreas are evident prior to the onset of diabetes and may be a useful early marker for increased risk of developing Type I or Type II diabetes. The amount of vesicular monoamine transporter (VMAT2), which is expressed by the beta cells of the pancreas, may reflect beta cell mass. Molecular imaging of beta cells using a VMAT2-targeted compound has the potential to detect losses in beta cells before a diagnosis of diabetes is possible by current methods. This may make it possible to identify individuals who are at elevated risk of developing diabetes to receive earlier treatment, and allow for monitoring of new treatments designed to preserve beta cells.

There are 20.8 million children and adults with diabetes in the United States alone (7 percent of the population). Diabetes mellitus (DM) is on the rise globally and is associated with an increased risk for serious, life-threatening complications including heart disease and stroke. Proactive disease control can help reduce risk; however, many people are not aware that they are at risk of diabetes until they develop one of its complications.

For more information: www.avidrp.com

Related Content

NIH Study of Brain Energy Patterns Provides New Insights into Alcohol Effects

NIH scientists present a new method for combining measures of brain activity (left) and glucose consumption (right) to study regional specialization and to better understand the effects of alcohol on the human brain. Image courtesy of Ehsan Shokri-Kojori, Ph.D., of NIAAA.

News | Neuro Imaging | March 22, 2019
March 22, 2019 — Assessing the patterns of energy use and neuronal activity simultaneously in the human brain improve
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Researchers Create New Method for Developing Cancer Imaging Isotopes

Prototype fluidic system for zirconium-89 purification. Image taken through a hot cell window at the Department of Radiology, University of Washington. Image courtesy of Matthew O’Hara, Pacific Northwest National Laboratory

News | Radiopharmaceuticals and Tracers | March 14, 2019
A team of researchers at the University of Washington announced they developed a new automated system for producing...
Siemens Healthineers Announces First U.S. Install of Biograph Vision PET/CT
News | PET-CT | March 06, 2019
Siemens Healthineers’ new Biograph Vision positron emission tomography/computed tomography (PET/CT) system has been...
ImaginAb Enrolls First Patient in Phase II PET Agent Clinical Trial
News | Radiopharmaceuticals and Tracers | January 30, 2019
ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell...
FDA Clears United Imaging Healthcare uExplorer Total-Body Scanner
Technology | PET-CT | January 23, 2019
January 23, 2019 — United Imaging Healthcare (United Imaging) announced U.S.
Subtle Medical Receives FDA Clearance, CE Mark for SubtlePET
Technology | PET Imaging | December 05, 2018
Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtlePET. Subtle...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...